The Latest Breaking News from Weight Loss

Metsera, Inc. (NASDAQ:MTSR) on Tuesday released topline data from VESPER-1 and data from a planned interim analysis for tolerability of VESPER-3 – two Phase 2b trials of MET-097i with potential for monthly dosing.

As the battle for dominance heats up in the weight loss market, which stock is a better investment now?

A new study found that nearly half of weight loss jab users had obtained the drug without a prescription, experts warn the consequences could be fatal

Gogglebox star Amy Tapper has made a plea for weight loss injections to be more easily available on the NHS for those people who need it.

Penny says she 'constantly' analysed her body when she was a model - and told us that she's 'all or nothing' when it comes to dropping a few pounds

Number of procedures on men up by 26% as experts say cosmetic surgery has become normalised despite risks

With a growing number of people turning to weight loss drugs, a new study suggests that some weight loss drugs work better than others depending on your DNA.

One admitted they “eat terribly,” one went to “fat camp,” and another “lost [their] a*se” while on Ozempic. Here’s what the stars said about weight-loss meds.

Roche Holdings AG (OTC:RHHBY) on Monday outlined its plan to become a leading player in the surging weight-loss drug market, pushing its obesity pipeline farther into late-stage development as it eyes competition with Eli Lilly And Co. (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO).